Vectin Chewable wormer tablets for horses 60 pack-Hyperdrug

Chewable apple flavoured ivermectin tablet wormer for horses. Each tablet treats 110kg

Vectin is to be administered orally as a single treatment. The product contains a flavour and will be taken voluntarily by most horses. The product can either be administered by hand, similar to a treat, or mixed with a small amount of feed. It should be ensured that the horse consumes the entire dose.

Vectin Chewable Tablets for horses . To ensure administration of a correct dose, the body weight should be determined as accurately as possible.

The dose scheme provides for a minimum dose of 0.2 mg ivermectin per kg body weight. One chewable tablet is adequate for the treatment of up to 110 kg body weight. For higher body weights, a corresponding number of chewable tablets should be chosen according to the following dose scheme:

Presentation One chewable tablet contains: Active substance: Ivermectin 22.75 mg. Uses Antiparasitic for the treatment of horses infected with adult and immature stages of the following gastro-intestinal nematodes, lungworms, microfilariae and stomach bots: (See table.) Vectin 22.75 mg Chewable Tablets may be used against: Large strongyles Strongylus vulgaris adults and 4th stage larvae (arterial stages) S. edentatus adults and 4th stage larvae (tissue stages) S. equinus adults Small strongyles Triodontophorus spp. adults T. brevicauda T. serratus T. tenuicollis Craterostomum acuticaudatum adults Coronocyclus spp. adults and intraluminal 4th stage larvae C. coronatus C. labiatus C. labratus Cyathostomum spp. adults and intraluminal 4th stage larvae C. catinatum C. pateratum Cylicocyclus spp. adults and intraluminal 4th stage larvae C. ashworthi C. elongatus C. insigne C. leptostomum C. nassatus C. radiatus Cylicodontophorus spp. adults and intraluminal 4th stage larvae C. bicoronatus Cylicostephanus spp. adults and intraluminal 4th stage larvae C. asymetricus C. bidentatus C. calicatus C. goldi C. longibursatus C. minutus Gyalocephalus capitatus adults and intraluminal 4th stage larvae Parapoteriostomum spp. adults and intraluminal 4th stage larvae P. euproctus P. mettami Petrovinema spp. adults and intraluminal 4th stage larvae P. poculatum Poteriostomum spp. adults and intraluminal 4th stage larvae P. imparidentatum P. ratzii Pinworms Oxyuris equi adults and immature stages Large-mouth stomach worms Habronema muscae adults and skin larvae Draschia spp. skin larvae Ascarids Parascaris equorum adults, 3rd and 4th stage larvae Hairworms Trichostrongylus axei adults Neck threadworms Onchocerca spp. microfilariae Stomach bots Gasterophilus spp. all larval stages Lungworms Dictyocaulus arnfieldi adults and immature stages Intestinal threadworms Strongyloides westeri adults Dermatitis caused by skin larvae of Habronema and Draschia spp. (summer sores) or by Onchocerca sp. microfilariae (skin onchocercosis).

Vectin can be used in horses with a bodyweight of 60 kg and above. To ensure administration of a correct dose, the body weight should be determined as accurately as possible.

Body weight of the horse (kg):

Number of Vectin chewable tablets to be administered:

60 to 110

1

111 to 220

2

221 to 330

3

331 to 440

4

441 to 550

5

551 to 660

6

etc.

etc.

Contra-indications, warnings, etc Do not use in horses weighing less than 60 kg. Do not use in horses known to be hypersensitive to the active ingredient or any of the excipients. Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: •Over-frequent and repeated use of anthelmintics from the same class, over an extended period of time. •Underdosing, which may be due to underestimation of body weight or maladministration of the product. Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. faecal egg count reduction test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Resistance to ivermectin has been reported in Parascaris equorum in horses. Therefore, the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics. Veterinary advice should be given on appropriate dosing programmes and stock management to achieve adequate parasite control and reduce the likelihood of anthelmintic resistance developing. In the event that a product is suspected of being ineffective, the animal owner is advised to seek veterinary advice. After the administration of ivermectin to dogs, cases of intolerance with a fatal outcome have been reported, especially in Collies, Old English Sheepdogs and related breeds or crosses, and also in turtles/tortoises. Vectin is registered for horses and should not be used in other animal species. Dogs or cats may be adversely affected by the ivermectin in this product if they are allowed to ingest dropped or discarded tablets or have access to used packaging material. Occasionally, some horses heavily infected with Onchocerca microfilariae have developed oedema and pruritus following dosing, assumed to be due to the death of large numbers of microfilariae. These signs resolve within a few days but symptomatic treatment may be advisable. On very rare occasions, colic, diarrhoea and anorexia have been reported post treatment, in particular when there is heavy worm burden. On very rare occasions, allergic reactions such as hypersalivation, lingual oedema and urticaria, tachycardia, congested mucous membranes, and subcutaneous oedema have been reported following treatment with the product. Studies have demonstrated there are no adverse effects when horses are administered up to three times the recommended dose. Mild transitory signs (slowed pupillary light response and depression) have been seen at a dose of 1.8 mg/kg. Other signs seen at higher doses include mydriasis, ataxia, tremors, stupor, coma and death. The less severe signs have been transitory. There is no known antidote but if signs of toxicity appear, symptomatic therapy is recommended. Operator warnings Do not eat, drink or smoke while handling the product. Wash your hands thoroughly with water and soap immediately after use of the product. Since this veterinary medicinal product can irritate eyes, any contact with the eyes should be avoided while using the product. If accidental exposure occurs, flush eyes immediately with plenty of water. In case of accidental ingestion or eye irritation, seek medical advice immediately and show the package leaflet or the label to the physician. Withdrawal period Meat and offal: 52 days. The product is not authorised for use in mares producing milk for human consumption. For animal treatment only. Keep out of the reach and sight of children. Pharmaceutical precautions Protect from light. Store blisters below 25°C. Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with national requirements. EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface waters or ditches with the product or used container.